With reference to the earlier letter dated April 25, 2016, Cadila Healthcare has now informed that the Board of Directors at its meeting to be held on May 13, 2016, to raise funds by issue of Equity Shares / convertible Bonds / Debentures through Qualified Institutional Placement [QIP] / GDR / ADR for an aggregate amount up to Rs 10,000 Crores, to issue Secured / Unsecured Redeemable Non-Convertible Debentures on private placement basis for an amount up to Rs 3500 Crores in the Financial Year 2016-17, and to issue Secured / Unsecured Foreign Currency Rated Bonds / Foreign Currency Convertible Bonds for an amount up to Rs 5000 Crores for raising funds / issuance of securities, which will be subject to approval of the members.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: